| Literature DB >> 35741133 |
Carmen Cutolo1, Federica De Muzio2, Roberta Fusco3, Igino Simonetti4, Andrea Belli5, Renato Patrone5, Francesca Grassi6,7, Federica Dell'Aversana6, Vincenzo Pilone1, Antonella Petrillo4, Francesco Izzo5, Vincenza Granata4.
Abstract
In the recent years, the number of liver resections has seen an impressive growth. Usually, hepatic resections remain the treatment of various liver diseases, such as malignant tumors, benign tumors, hydatid disease, and abscesses. Despite technical advancements and tremendous experience in the field of liver resection of specialized centers, there are moderately high rates of postoperative morbidity and mortality, especially in high-risk and older patient populations. Although ultrasonography is usually the first-line imaging examination for postoperative complications, Computed Tomography (CT) is the imaging tool of choice in emergency settings due to its capability to assess the whole body in a few seconds and detect all possible complications. Magnetic resonance cholangiopancreatography (MRCP) is the imaging modality of choice for delineating early postoperative bile duct injuries and ischemic cholangitis that may arise in the late postoperative phase. Moreover, both MDCT and MRCP can precisely detect tumor recurrence. Consequently, radiologists should have knowledge of these surgical procedures for better comprehension of postoperative changes and recognition of the radiological features of various postoperative complications.Entities:
Keywords: hepatectomy; postoperative complications; radiologists
Year: 2022 PMID: 35741133 PMCID: PMC9221607 DOI: 10.3390/diagnostics12061323
Source DB: PubMed Journal: Diagnostics (Basel) ISSN: 2075-4418
Figure 1Postsurgical biloma assessed with MRI at 1 week post resection of VIII segment for liver metastasis. The biloma (arrow) appears hyperintense in T2 (A,B) sequences of MRI study.
Figure 2Hepatic abscess in resected cholangiocarcinoma on VI hepatic segment, evaluated with MRI. Arrow shows air artifacts within the collection and hyperenhancement of hepatic parenchymal in arterial phase (A) of contrast study that disappears in portal (B) and hepatobiliary (C) phase of contrast study.
Figure 3Hepatic abscess in resected hepatocellular carcinoma on VI hepatic segment, evaluated with CT. Arrow shows air artifacts within the collection in arterial (A) and portal (B) phase of contrast study.
Figure 4CT-guided hepatic infected biloma drainage (arrows) and postprocedure assessment in portal phase of contrast study in axial (A) and coronal (B) plane.
Figure 5Active bleeding (arrow) during arterial (A), portal (B), and late (C) phase of contrast study. In (D), arrow shows contrast collection in perihepatic space.
Figure 6CT portal phase assessment in resected liver metastases patient. The arrow shows (A,B) mild portal thrombosis.
Figure 7Bile leaks assessed with MRI T2-W sequence (A) and hepatospecific phase of contrast study (B). Arrow shows leak.
Figure 8CT assessment in colorectal metastasis-resected patient (A). In (B), arrow shows a new lesion.
Figure 9Patient with hepatosarcoma evaluated with MRI study ((A): T2-W sequence and (B): portal phase of contrast study). At MRI 6-month evaluation of arterial phase (C) and cholangiography (D) sequences show biliary strictures (arrow).